drugset / Trial / NCT00258947

Evaluation of Take and Safety of a Smallpox Vaccine in Healthy Young Adults

NCT00258947

Phase 2 Completed 230 enrolled Sanofi
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Primary Objective: To estimate the smallpox vaccination take rate in healthy young adults not previously vaccinated with a smallpox vaccine. Secondary Objectives: To describe antibody response to vaccination and evaluate the take for each subject at various timepoints for each batch and pooled batches and to evaluate local signs, symptoms, and overall safety in healthy young adults not previously vaccinated with a smallpox vaccine.

Timeline

Start
2005-09
Primary completion
2006-12
Completion
2007-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Smallpox vaccine Vaccine